Fennec Pharmaceuticals (FENC) Shares Outstanding (2010 - 2025)

Fennec Pharmaceuticals (FENC) has 16 years of Shares Outstanding data on file, last reported at $34.2 million in Q4 2025.

• For the quarter ending Q4 2025, Shares Outstanding rose 24.11% year-over-year to $34.2 million; the trailing twelve-month figure through Dec 2025 stood at $34.2 million (up 24.11% YoY), and the FY2025 full-year result was $34.2 million, up 24.11% from the prior year.
• Shares Outstanding for Q4 2025 stood at $34.2 million, up from $28.1 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $34.2 million in Q4 2025 and bottomed at $26.0 million in Q1 2021.
• The 5-year median for Shares Outstanding is $26.6 million (2023), against an average of $27.1 million.
• Peak annual rise in Shares Outstanding reached 30.69% in 2021, while the deepest fall reached 0.04% in 2021.
• A 5-year view of Shares Outstanding shows it stood at $26.0 million in 2021, then gained by 1.33% to $26.4 million in 2022, then climbed by 2.53% to $27.0 million in 2023, then increased by 1.85% to $27.5 million in 2024, then rose by 24.11% to $34.2 million in 2025.
• The last three Shares Outstanding figures came in at $34.2 million (Q4 2025), $28.1 million (Q3 2025), and $27.7 million (Q2 2025), per Business Quant data.

Peer Comparison